Moustafa Salaheldin Abdelhamid
Overview
Explore the profile of Moustafa Salaheldin Abdelhamid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdelhamid M, Eraky S, El-Deen I, Elian Sophy M
Future Med Chem
. 2025 Jan;
17(2):209-219.
PMID: 39829378
Background: Using an analogue-based drug design approach, a number of novel 2-substituted-1,3-thiazolone derivatives (3-10) have been produced and given permission to proceed for their anti-inflammatory properties. In the present paper,...
2.
Abdelsalam H, Samy A, Mosaleem E, Abdelhamid M
Sci Rep
. 2024 Nov;
14(1):26888.
PMID: 39505968
Uremic Encephalopathy results from the elevation of toxins and blood-brain barrier (BBB) disruption. Renal Ischemia/Reperfusion (I/R) injury is the principal cause of acute kidney injury and brain tissue injury. The...
3.
Abdelhamid M, Sherif M, Abaza H, El-Maghraby L, Watad S, Awad A
Food Sci Nutr
. 2024 Mar;
12(3):1940-1954.
PMID: 38455204
Obesity became a serious public health problem with enormous socioeconomic implications among the Egyptian population. The present investigation aimed to explore the efficacy of extract as a hypolipidemic agent combined...
4.
Abdelhamid M, El-Farargy A, Abdelhai Esawi O
Anticancer Drugs
. 2023 Feb;
34(4):563-581.
PMID: 36847066
Progesterone receptor (PR) agonists represent pivotal agents in trapping breast cancer cells through modulating the expression of estrogen receptor (ER). The present investigation aimed to test three novel thiadiazole-containing compounds...
5.
Abdel-Hamid N, Sherif M, Al Samahy A, Abdelhamid M
Asian Pac J Cancer Prev
. 2022 Nov;
23(11):3815-3823.
PMID: 36444594
Background: Hepatocellular carcinoma (HCC) is a possible oncogenic progression during persistent hepatitis C-infection +/- type II diabetes mellitus (DM). We aim to investigate the plasma insulin, erythrocytic aldose reductase (AR)...